These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9848196)

  • 21. [Carboxypeptidase T--intracellular carboxypeptidase of Thermoactinomycetes--a distant analog of animal carboxypeptidase].
    Osterman AL; Stepanov VM; Rudenskaia GN; Khodova OM; Tsaplina IA
    Biokhimiia; 1984 Feb; 49(2):292-301. PubMed ID: 6424730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor.
    Fromm JR; Hileman RE; Caldwell EE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1995 Nov; 323(2):279-87. PubMed ID: 7487089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-sweetness relationship in egg white lysozyme: role of lysine and arginine residues on the elicitation of lysozyme sweetness.
    Masuda T; Ide N; Kitabatake N
    Chem Senses; 2005 Oct; 30(8):667-81. PubMed ID: 16162643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of kininases.
    Erdös EG
    Fed Proc; 1979 Dec; 38(13):2774-7. PubMed ID: 228988
    [No Abstract]   [Full Text] [Related]  

  • 25. [Enzyme immobilization on hydroxyalkylmethacrylate carrier Separon E - properties of immobilized enzymes and their prospective uses in medicine (author's transl)].
    Rybák M; Coupek J
    Cas Lek Cesk; 1980 Sep; 119(39):1055-7. PubMed ID: 7002314
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of captopril and reserpine on the activity of certain neuropeptide metabolism enzymes].
    Gengin MT; Vernigora AN; Nikishin NN; Makeeva NV
    Vopr Med Khim; 1995; 41(5):37-9. PubMed ID: 8553625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and function of human plasma carboxypeptidase N, the anaphylatoxin inactivator.
    Skidgel RA; Erdös EG
    Int Immunopharmacol; 2007 Dec; 7(14):1888-99. PubMed ID: 18039526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic activity of carboxypeptidase B and of carboxypeptidase Y with anisylazoformyl substrates.
    Mock WL; Xu D
    Bioorg Med Chem Lett; 1999 Jan; 9(2):187-92. PubMed ID: 10021925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode.
    Arolas JL; Popowicz GM; Lorenzo J; Sommerhoff CP; Huber R; Aviles FX; Holak TA
    J Mol Biol; 2005 Jul; 350(3):489-98. PubMed ID: 15961103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tissue and regional distribution of activity of phenylmethylsulfonyl fluoride inhibited carboxypeptidase and other carboxypeptidases in rats].
    Shchetinina NV; Vernigora AN; Gengin MT; Firstova NV
    Ukr Biokhim Zh (1978); 1997; 69(3):23-8. PubMed ID: 9505357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immobilized carboxypeptidase N. A potent bioreactor and specific adsorbent for peptides.
    Wang W; Hendriks DF; Scharpé SL
    Appl Biochem Biotechnol; 1994 Feb; 44(2):151-60. PubMed ID: 8017900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carboxypeptidase activity in human mycoplasmas.
    Shibata K; Watanabe T
    J Bacteriol; 1986 Nov; 168(2):1045-7. PubMed ID: 3096956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NMR structure and dynamics of the two-domain tick carboxypeptidase inhibitor reveal flexibility in its free form and stiffness upon binding to human carboxypeptidase B.
    Pantoja-Uceda D; Arolas JL; García P; López-Hernández E; Padró D; Aviles FX; Blanco FJ
    Biochemistry; 2008 Jul; 47(27):7066-78. PubMed ID: 18558717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical modification of lysine and arginine residues of bovine heart 2-oxoglutarate dehydrogenase: effect on the enzyme activity and regulation.
    Ostrovtsova SA
    Acta Biochim Pol; 1998; 45(4):1031-6. PubMed ID: 10397349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclobutane-containing peptides: evaluation as novel metallocarboxypeptidase inhibitors and modelling of their mode of action.
    Fernández D; Torres E; Avilés FX; Ortuño RM; Vendrell J
    Bioorg Med Chem; 2009 Jun; 17(11):3824-8. PubMed ID: 19414265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of the digestive system of Helicoverpa zea to ingestion of potato carboxypeptidase inhibitor and characterization of an uninhibited carboxypeptidase B.
    Bayés A; de la Vega MR; Vendrell J; Aviles FX; Jongsma MA; Beekwilder J
    Insect Biochem Mol Biol; 2006 Aug; 36(8):654-64. PubMed ID: 16876708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of chemotaxis.
    Maderazo EG; Woronick CL; Ward PA
    Methods Enzymol; 1988; 162():223-35. PubMed ID: 3226307
    [No Abstract]   [Full Text] [Related]  

  • 38. Ligand bindings of bovine carboxypeptidase B. II. Affinity chromatography and cooperative ligations.
    Sukenaga Y; Akanuma H; Suekane C; Yamasaki M
    J Biochem; 1980 Mar; 87(3):695-707. PubMed ID: 7390958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High performance liquid chromatographic quantitation of carboxypeptidase activity secreted by human hep G2 cells.
    Grimwood BG; Tarentino AL; Plummer TH
    Anal Biochem; 1988 Apr; 170(1):264-8. PubMed ID: 2839052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human carboxypeptidase N: lysine carboxypeptidase.
    Skidgel RA
    Methods Enzymol; 1995; 248():653-63. PubMed ID: 7674952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.